Corp 1000

Pfizer expects 2023 sales to decline as much as 33% compared with record-breaking 2022

The pharmaceutical company booked $100.3 billion for full-year 2022, an all-time high.

Previous post Spotify shares pop 12% on strong user growth
Next post UBS gets a boost from higher interest rates, but warns of ‘uncertain’ year ahead